Connection

Co-Authors

This is a "connection" page, showing publications co-authored by Sung-Han Kim and Seongman Bae.
Connection Strength

8.511
  1. Adverse Reactions Following the First Dose of ChAdOx1 nCoV-19 Vaccine and BNT162b2 Vaccine for Healthcare Workers in South Korea. J Korean Med Sci. 2021 May 03; 36(17):e115.
    View in: PubMed
    Score: 0.943
  2. Transmission Characteristics of SARS-CoV-2 That Hinder Effective Control. Immune Netw. 2021 Feb; 21(1):e9.
    View in: PubMed
    Score: 0.931
  3. Recent Hydroxychloroquine Use Is Not Significantly Associated with Positive PCR Results for SARS-CoV-2: A Nationwide Observational Study in South Korea. Viruses. 2021 02 20; 13(2).
    View in: PubMed
    Score: 0.930
  4. Effects of Recent Use of Renin-Angiotensin System Inhibitors on Mortality of Patients With Coronavirus Disease 2019. Open Forum Infect Dis. 2020 Nov; 7(11):ofaa519.
    View in: PubMed
    Score: 0.910
  5. Notice of Retraction: Effectiveness of Surgical and Cotton Masks in Blocking SARS-CoV-2. Ann Intern Med. 2020 07 07; 173(1):79.
    View in: PubMed
    Score: 0.885
  6. Effectiveness of Surgical and Cotton Masks in Blocking SARS-CoV-2: A Controlled Comparison in 4 Patients. Ann Intern Med. 2020 07 07; 173(1):W22-W23.
    View in: PubMed
    Score: 0.876
  7. The Detailed Kinetics of Cytomegalovirus-specific T cell Responses after Hematopoietic Stem Cell Transplantation: 1 Year Follow-up Data. Immune Netw. 2018 Apr; 18(2):e2.
    View in: PubMed
    Score: 0.752
  8. Frequent Occurrence of SARS-CoV-2 Transmission among Non-close Contacts Exposed to COVID-19 Patients. J Korean Med Sci. 2021 Aug 23; 36(33):e233.
    View in: PubMed
    Score: 0.241
  9. Diagnostic usefulness of subgenomic RNA detection of viable SARS-CoV-2 in patients with COVID-19. Clin Microbiol Infect. 2022 Jan; 28(1):101-106.
    View in: PubMed
    Score: 0.240
  10. Immune responses and reactogenicity after ChAdOx1 in individuals with past SARS-CoV-2 infection and those without. J Infect. 2022 01; 84(1):94-118.
    View in: PubMed
    Score: 0.240
  11. SARS-CoV-2-Specific Antibody and T Cell Response Kinetics According to Symptom Severity. Am J Trop Med Hyg. 2021 Jun 17; 105(2):395-400.
    View in: PubMed
    Score: 0.238
  12. Nosocomial Outbreak of COVID-19 in a Hematologic Ward. Infect Chemother. 2021 Jun; 53(2):332-341.
    View in: PubMed
    Score: 0.237
  13. Adverse Reactions of the Second Dose of the BNT162b2 mRNA COVID-19 Vaccine in Healthcare Workers in Korea. J Korean Med Sci. 2021 May 31; 36(21):e153.
    View in: PubMed
    Score: 0.237
  14. Factors of Severity in Patients with COVID-19: Cytokine/Chemokine Concentrations, Viral Load, and Antibody Responses. Am J Trop Med Hyg. 2020 12; 103(6):2412-2418.
    View in: PubMed
    Score: 0.228
  15. Effectiveness of surgical, KF94, and N95 respirator masks in blocking SARS-CoV-2: a controlled comparison in 7 patients. Infect Dis (Lond). 2020 Nov - Dec; 52(12):908-912.
    View in: PubMed
    Score: 0.225
  16. Contamination of personal protective equipment by SARS-CoV-2 during routine care of patients with mild COVID-19. J Infect. 2020 08; 81(2):e165-e167.
    View in: PubMed
    Score: 0.222
  17. Delayed local reactions after the first administration of the ChAdOx1 nCoV-19 vaccine. Allergy. 2021 11; 76(11):3520-3522.
    View in: PubMed
    Score: 0.060
  18. Risk factors for isolation of multi-drug resistant organisms in coronavirus disease 2019 pneumonia: A multicenter study. Am J Infect Control. 2021 10; 49(10):1256-1261.
    View in: PubMed
    Score: 0.059
  19. Clinical and Virologic Effectiveness of Remdesivir Treatment for Severe Coronavirus Disease 2019 (COVID-19) in Korea: a Nationwide Multicenter Retrospective Cohort Study. J Korean Med Sci. 2021 Mar 22; 36(11):e83.
    View in: PubMed
    Score: 0.058
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.